Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism

[1]  J. Montani,et al.  Arginase II Promotes Macrophage Inflammatory Responses Through Mitochondrial Reactive Oxygen Species, Contributing to Insulin Resistance and Atherogenesis , 2012, Journal of the American Heart Association.

[2]  J. B. Lopes de Faria,et al.  Uncoupling Endothelial Nitric Oxide Synthase Is Ameliorated by Green Tea in Experimental Diabetes by Re-establishing Tetrahydrobiopterin Levels , 2012, Diabetes.

[3]  M. Okusa,et al.  Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. , 2011, American journal of physiology. Renal physiology.

[4]  S. Morris,et al.  Arginase-2 Mediates Diabetic Renal Injury , 2011, Diabetes.

[5]  Hyung-Suk Kim,et al.  A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy , 2011, Proceedings of the National Academy of Sciences.

[6]  S. Giunti,et al.  Targeting the MCP-1/CCR2 System in diabetic kidney disease. , 2010, Current vascular pharmacology.

[7]  D. Williamson,et al.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.

[8]  S. Morris,et al.  Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.

[9]  P. Krishan,et al.  Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  J. Boucher,et al.  Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. , 2008, American journal of respiratory and critical care medicine.

[11]  C. Irvin,et al.  Inhibition of Arginase Activity Enhances Inflammation in Mice with Allergic Airway Disease, in Association with Increases in Protein S-Nitrosylation and Tyrosine Nitration1 , 2008, The Journal of Immunology.

[12]  Guoyao Wu,et al.  Arginase blockade protects against hepatic damage in warm ischemia-reperfusion. , 2008, Nitric oxide : biology and chemistry.

[13]  Y. Guillaume,et al.  Treatment with the arginase inhibitor Nω-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat , 2008, Journal of hypertension.

[14]  A. Shoukas,et al.  Mitochondrial arginase II constrains endothelial NOS-3 activity. , 2007, American journal of physiology. Heart and circulatory physiology.

[15]  A. Burnett,et al.  Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. , 2007, American journal of physiology. Heart and circulatory physiology.

[16]  Guoyao Wu,et al.  Liver I/R injury is improved by the arginase inhibitor, Nω-hydroxy-nor-l-arginine (nor-NOHA) , 2007 .

[17]  Liping Huang,et al.  Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. , 2006, American journal of physiology. Renal physiology.

[18]  O. Levillain,et al.  Mitochondrial Expression of Arginase II in Male and Female Rat Inner Medullary Collecting Ducts , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  O. Levillain,et al.  Localization and differential expression of arginase II in the kidney of male and female mice , 2005, Pflügers Archiv.

[20]  R. Carey,et al.  Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade , 2004, Journal of hypertension.

[21]  A. Shoukas,et al.  Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels , 2003, Circulation.

[22]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[23]  D. Christianson,et al.  Arginase and autoimmune inflammation in the central nervous system , 2003, Immunology.

[24]  M. Goligorsky,et al.  Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. , 2002, American journal of physiology. Heart and circulatory physiology.

[25]  D. Shih,et al.  Paradoxical Reduction of Fatty Streak Formation in Mice Lacking Endothelial Nitric Oxide Synthase , 2002, Circulation.

[26]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[27]  F. Cuccurullo,et al.  Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. , 2001, Free radical biology & medicine.

[28]  L. Kuo,et al.  Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide‐mediated vasodilatory function , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  M. Goligorsky,et al.  Glucose scavenging of nitric oxide. , 2001, American journal of physiology. Renal physiology.

[30]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[31]  M. Goligorsky,et al.  Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide , 2001, Hypertension.

[32]  H. Zoghbi,et al.  Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene , 2001, Molecular and Cellular Biology.

[33]  D. Levine,et al.  Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors. , 2001, American journal of physiology. Renal physiology.

[34]  K. Matsushima,et al.  Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. , 2000, Kidney international.

[35]  M. Cooper,et al.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? , 1999, Kidney international.

[36]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[37]  S. Morris,et al.  Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. , 1998, American journal of physiology. Endocrinology and metabolism.

[38]  S. Morris,et al.  Human type II arginase: sequence analysis and tissue-specific expression. , 1997, Gene.

[39]  J. Warren,et al.  Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. , 1996, Kidney international.

[40]  S. Yagihashi,et al.  Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats , 1996, Diabetologia.

[41]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Tipping,et al.  Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[43]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[44]  B. Croker,et al.  Endothelial dysfunction as a potential contributor in diabetic nephropathy , 2011, Nature Reviews Nephrology.

[45]  S. Morris,et al.  Determination of mammalian arginase activity. , 2008, Methods in enzymology.

[46]  R. Harris,et al.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. , 2006, Journal of the American Society of Nephrology : JASN.

[47]  G. Remuzzi,et al.  J Am Soc Nephrol 14: 1816–1824, 2003 Add-On Anti–TGF- � Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat , 2022 .

[48]  P. Tipping,et al.  Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. , 1991, Kidney international.